ASX:4DX

ASX News·ASX:4DX·Medical Technology·News·Stock Market

4DMedical Shares Move Higher Pre-Market With Test Ahead for 4DX

4DMedical shares closed at A$4.17 on Friday, up 8.88% on heavy volume, outpacing the S&P/ASX 200’s 0.11% drop. The lung-imaging firm joined the ASX 200 in April and recently announced a one-year analytics deal with GlaxoSmithKline. No new contracts or earnings were disclosed Friday. Normal trading resumes Monday in Sydney.

May 17, 2026

China’s PMI Impact on ASX Resource Stocks
June 1, 2026, 10:48 PM EDT. China's Purchasing Managers' Index (PMI), a key economic indicator measuring manufacturing activity, is emerging as a subtle yet significant driver behind the performance of Australian Securities Exchange (ASX) resource stocks. The PMI reflects economic health by indicating expansion or contraction in manufacturing, directly influencing demand for commodities. As China remains Australia's largest trading partner, fluctuations in its PMI can signal shifts in commodity demand, impacting share prices of resource companies listed on the ASX. Understanding this relationship is crucial for investors navigating markets reliant on global trade dynamics, particularly amid evolving economic conditions in China.